+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia



Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia



Human Genetics 115(1): 29-35



The activity of complex I of the mitochondrial respiratory chain has been found to be decreased in patients with Parkinson's disease (PD), but no mutations have been identified in genes encoding complex I subunits. Recent studies have suggested that polymorphisms in mitochondrial DNA (mtDNA)-encoded complex I genes (MTND) modify susceptibility to PD. We hypothesize that the risk of PD is conveyed by the total number of nonsynonymous substitutions in the MTND genes in various mtDNA lineages rather than by single mutations. To test this possibility, we determined the number of nonsynonymous substitutions of the seven MTND genes from 183 Finns. The differences in the total number of nonsynonymous substitutions and the nonsynonymous to synonymous substitution rate ratio ( K(a)/ K(s)) of MTND genes between the European mtDNA haplogroup clusters (HV, JT, KU, IWX) were analysed by using a statistical approach. Patients with PD ( n=238) underwent clinical examination together with mtDNA haplogroup analysis and the clinical features between patient groups defined by the number of nonsynonymous substitutions were compared. Our analysis revealed that the haplogroup clusters HV and KU had a lower average number of amino acid replacements and a lower K(a)/ K(s) ratio in the MTND genes than clusters JT and IWX. Supercluster JTIWX with the highest number of amino acid replacements was more frequent among PD patients and even more frequent among patients with PD who developed dementia. Our results suggest that a relative excess of nonsynonymous mutations in MTND genes in supercluster JTWIX is associated with an increased risk of PD and the disease progression to dementia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012310486

Download citation: RISBibTeXText

PMID: 15108120

DOI: 10.1007/s00439-004-1123-9


Related references

Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study. Movement Disorders 21(12): 2170-2174, 2006

Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia. Brain Pathology 28(1): 43-57, 2018

Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease. Brain and Behavior 8(3): E00916, 2018

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts. JAMA Neurology 75(6): 704-710, 2018

Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. International Journal of Geriatric Psychiatry 19(4): 371-377, 2004

Mitochondrial DNA polymorphisms and the risk of Parkinson's disease in Taiwan. Journal of Neural Transmission 114(8): 1017-1021, 2007

Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. Journal of the Neurological Sciences 236(1-2): 49-54, 2005

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease. American Journal of Human Genetics 72(4): 4-11, 2003

Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study. Movement Disorders 17(2): 250-257, 2002

Evaluation of doctor/patient satisfaction with the use of the Parkinson's Disease Dementia-Short-Screen (PDD-SS): a screening test for dementia in Parkinson's disease (DIFFUSION study). Neurologia 26(8): 461-467, 2011

Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions. Journal of Neurochemistry 150(5): 467-474, 2019

A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease. Neuroepidemiology 37(3-4): 222-230, 2011

Do physical exercise and reading reduce the risk of Parkinson's disease? a cross-sectional study on factors associated with Parkinson's disease in elderly Chinese veterans. Neuropsychiatric Disease and Treatment 11: 695-700, 2015

Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease. Zhonghua Yi Xue Za Zhi 96(21): 1664-1667, 2016

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathologica 120(2): 131-143, 2010